Subject
Radiology, Nuclear Medicine and imaging,Oncology,Hematology
Reference47 articles.
1. Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy;Varadhachary;Ann Surg Oncol,2006
2. Petrelli F, Coinu A, Borgonovo K, Cabiddu M, Ghilardi M, Lonati V, et al. FOLFIRINOX-based neoadjuvant therapy in borderline resectable or unresectable pancreatic cancer: a meta-analytical review of published studies. Pancreas 2015;44:515–21 [PMID: 25872127 DOI: 10.1097/MPA.0000000000000314]
3. Balaban EP, Mangu PB, Yee NS. Locally advanced unresectable pancreatic cancer: american society of clinical oncology clinical practice guideline summary. J Oncol Pract 2017;13:265–69 [PMID: 28399382 DOI: 10.1200/JOP.2016.017376].
4. NCCN Clinical Practice Guidelines in Oncology - Pancreatic Adenocarcinoma. Version 2.2021, February 25, 2021. URL: https://www.nccn.org/professionals/physician_gls/pdf/pancreatic.pdf.
5. Seufferlein T, Bachet JB, Van Cutsem E, Rougier P, Group EGW. Pancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2012;23:vii33–40 [PMID: 22997452 DOI: 10.1093/annonc/mds224].
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献